In the Media

Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!

Daiichi Sankyo gins up antibody research project with German research institute

Fierce Biotech

Read article Read our press release

BioMed X Institute launched a new collaboration with Daiichi Sankyo in cancer therapy

Medical Marketing + Media

Read article

BioMed X Institute launches new cancer collaboration with Daiichi Sankyo

bionity.com

Read article

BioMed X Institute joins forces with Daiichi Sankyo in cancer therapy

The Pharma Letter

Read article

Heidelberger BioMed X kooperiert mit Daiichi

transkript

Read article

Germany’s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy

BioSpectrum Asia

Read article

BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment

Contract Pharma

Read article

BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy

PharmiWeb.com

Read article

Collaboration targets multi-specific biologics for solid tumour treatment

Labmate Online

Read article

Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players

R&D World

Read article

Search our site

In the Media

Daiichi Sankyo gins up antibody research project with German research institute

BioMed X Institute launched a new collaboration with Daiichi Sankyo in cancer therapy

BioMed X Institute launches new cancer collaboration with Daiichi Sankyo

BioMed X Institute joins forces with Daiichi Sankyo in cancer therapy

Heidelberger BioMed X kooperiert mit Daiichi

Germany’s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy

BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment

BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy

Collaboration targets multi-specific biologics for solid tumour treatment

Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players

Learn more about BioMed X

Press Releases

About BioMed X